Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2025-12-31 @ 10:15 PM
Study NCT ID:
NCT05973604
Status:
UNKNOWN
Last Update Posted:
2023-08-03
First Post:
2023-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prevalence of Primary Aldosteronism in Atrial Fibrillation
Sponsor:
Aristotle University Of Thessaloniki
Organization:
Study Overview
Official Title:
Prevalence of Primary Aldosteronism in Patients With Atrial Fibrillation (ERETRIA Trial)
Status:
UNKNOWN
Status Verified Date:
2023-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ERETRIA
Brief Summary:
This is an observational prospective cross-sectional study, investigating the prevalence of primary aldosteronism in patients with atrial fibrillation.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: